🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Status
Recruiting
Location
The fourth hospital of Hebei Medical University
Start Date
2024-11-15
Trial ID
NCT06576921
Treatments Being Tested
This phase II trial compares the effect of adding radiation therapy to the ...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2023-10-18
Trial ID
NCT06350162
Treatments Being Tested
To evaluate the efficacy and safety of Serplulimab in Combination With Doce...
Status
Unknown
Location
Zhang Zizhen
Start Date
2023-03-01
Trial ID
NCT05769725
Treatments Being Tested
A single-center, single-arm, phase 2 trial of Serplulimab in combination wi...
Status
Unknown
Location
the Second Affiliated Hospital of Medical College of Zhejiang University
Start Date
2023-06-01
Trial ID
NCT05894837
Treatments Being Tested
This study is a prospective open-label, single-arm, single-center clinical ...
Status
Recruiting
Location
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2023-06-21
Trial ID
NCT05747729
Treatments Being Tested
This is a prospective, single arm, multicenter phase II study to assess the...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07-15
Trial ID
NCT06439550
Treatments Being Tested
To evaluate the efficacy and safety of Serplulimab in combination with Tras...
Status
Not Yet Recruiting
Location
the First Affiliated Hospital of the Air Force Medical University
Start Date
2026-03-25
Trial ID
NCT07466303
Treatments Being Tested
The goal of this clinical trial is to find out if adding a PD-1 antibody (s...
Status
Not Yet Recruiting
Location
Sun Yat-Sen University Cancer Center
Start Date
2025-12-29
Trial ID
NCT07277842
Treatments Being Tested
A Phase II Study of Serplulimab Plus Chemoradiotherapy as Adjuvant Treatmen...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2024-11-19
Trial ID
NCT06727617
Treatments Being Tested
China with high incidence of esophageal cancer, the number of new cases and...
Status
Active Not Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2022-12-01
Trial ID
NCT05659251
Treatments Being Tested